Cognizant to Acquire Zenith Technologies, a Leader in Life Sciences Manufacturing Technology Services
Cognizant (Nasdaq: CTSH) today announced that it has agreed to acquire Zenith Technologies, a privately held life science manufacturing technology service company, in Cork, Ireland. Zenith Technologies specializes in applying digital technologies to manage, control and optimize drug and medical equipment production for maximum operational efficiency and regulatory compliance.
This acquisition expands Cognizant's capabilities for the design, implementation and management of end-to-end operational and information technology systems related to extended biopharmaceutical and medical device manufacturers. Interconnected "smart factories" have become a strategic priority for the industry, in which production systems and processes have become more complex due to research progress and demand for large-molecular biology has increased.
Joint Cognizant-Zenith Technologies will provide a range of industry 4.0 capabilities from factory design consulting, machine sensor and controller instrumentation, supervisory control and data acquisition to executive systems, batch automation, enterprise resource planning integration and managed services. The operating hub of the company located in Ireland, Germany, India, Singapore, the United States and other sites around the world are located near the manufacturing facilities of many Cognizant customers. Cognizant is a leading service provider for the life science industry, working with the world's top 30 life science companies.
Cognizant's Chief Executive Officer Brian Humphries said, "Industry 4.0 Solutions, Internet of Things (IOTs), Automation and Analytics, is a strategic focus area for Cognizant." "In acquiring Zenith Technologies, we extend Cognizant's IoT portfolio and expand our life science domain expertise as a single-source provider of end-to-end smart factory capabilities. Convergence is better positioned to help in feeling the convergence. In their manufacturing activities, and life-saving medicines, biology, and Remaining pharmaceuticals and medical devices to leverage the development. We look forward to welcome Cognizant's employees Zenith Technologies. "
"After joining Cognizant, we are bringing two honored Life Science Service Providers brands with complementary technology and manufacturing operations expertise," said Hog, Chief Executive Officer, Zenith Technologies. "This is an exciting time for us, to enable more flexible and efficient manufacturing facilities with the life science industry, embracing digital transformation to bring new theories to the market faster. Our joint business manufacturing processes and systems Through efficient integration of the process excellence will operate, efficient. Information and analytics in manufacturing value chain And use 4.0 IoT technologies that deliver manufacturing 4.0 together, we are well positioned to help customers produce life-saving drugs and medical devices for those patients who need them most . "
The transaction is expected to close in the third quarter of 2019, which is subject to the satisfaction of the closing conditions, including the regulatory review. Financial details were not disclosed.
Founded in 1998, Zenith Technologies works on five continents, with 16 locations globally. Zenith Technologies works with nine of the world's 10 largest biopharmaceutical manufacturers, implementing and supporting their manufacturing lifecycle software through its consultancy, manufacturing digital and automation system integration, and manufacturing site services business lines.
A recognized industry leader, Zenith Technologies was named "Pharma Supplier of the Year" at the 2018 Pharma Industry Awards, which accept companies that show innovation and excellence in the Irish biopharma industry.
Over 800 people from Zenith Technologies will be part of Cognizant's Life Sciences Business Unit.
About Zenith Technologies
Zenith Technologies is a global company that specializes in full lifecycle automation, manufacturing and operational support solutions for the life science industry. Zenith Technologies operates closely with 16 global locations and all major life science manufacturing centers. For more information, visit www.zenithtechnologies.com.
About Cognizant
Cognizant (Nasdaq-100: CTSH) is one of the world's leading professional service companies, which is changing the business, operations and technology models of customers for the digital age. Our unique industry-based, consultative approach helps customers to create, run and run more innovative and efficient businesses. Headquartered in America, Cognizant is ranked 193rd on Fortune 500 and is consistently listed among the world's most acclaimed companies. Learn how Cognizant helps clients to digital leads at www.cognizant.com or follows us on Cognizant.
forward-looking statements
This press release contains such statements, which can form forward-looking statements made in accordance with the safe port provisions of the 1995 Personal Security Retention Reform Act, of which the accuracy is essentially subject to risks, uncertainties and assumptions which are in the future Events can not be as accurate as it proves. These statements include the expected closing of the acquisition of Zenith Technologies and the implications of the acquisition of Zenith Technologies on the business and prospects of Cognitive and Zenith Technologies, but express or implied, forward-limited-statements do not include. These statements are neither promises nor guarantees, but are subject to various risks and uncertainties, many of which are beyond our control, which can bring different real results from those contemplating these forward-looking statements. Existing and prospective investors are cautioned that they should not have undue reliance on these forward-looking statements, which only speak as a date. Factors that can create physical results for being physically different from express or implied, they discuss general economic conditions, changes in regulatory environment, immigration and taxes and other factors, which are discussed in our most recent annual Report Form 10-and other filings with the Securities and Exchange Commission and Securities and Exchange Commission. In case of new securities, future events, or otherwise, under the laws of applicable securities, except that no one takes cognitive responsibility for updating or modifying any further details.